RXO Statements
RX
Data from RXO`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
31 Dec, 2023
Next reporting period:
30 Mar, 2024
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
06 Feb, 2025
RXO Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
978
0.2 %
100
799
81.7
179
2.3 %
18.3
—
0
146
14.9
161
-1.8 %
16.5
18
63.6 %
1.8
-8
-0.8
-2
-0.2
4
233.3 %
0.4
2
0.2
2
300 %
0.2
0.017
119.58
976
1.3 %
100
801
82.1
175
-3.3 %
17.9
—
0
148
15.2
164
1.2 %
16.8
11
-42.1 %
1.1
-8
-0.8
-1
-0.1
-3
-150 %
-0.3
-2
-0.2
-1
-133.3 %
-0.1
-0.01
117
963
-4.7 %
100
782
81.2
181
-4.7 %
18.8
—
0
144
15
162
-5.3 %
16.8
19
—
2
-8
-0.8
—
0
6
300 %
0.6
3
0.3
3
—
0.3
0.03
119.5
1 010
-9.8 %
100
820
81.2
190
-13.2 %
18.8
—
0
153
15.1
171
-2.8 %
16.9
19
-55.8 %
1.9
-8
-0.8
—
0
-3
50 %
-0.3
-3
-0.3
—
100 %
0
—
119.4
1 120
-1.6 %
100
901
80.4
219
-2.7 %
19.6
—
0
155
13.8
176
-2.8 %
15.7
43
-2.3 %
3.8
-5
-0.4
—
0
-6
-140 %
-0.5
-2
-0.2
-4
-130.8 %
-0.4
-0.03
116.3
1 138
-7.2 %
100
913
80.2
225
-15.4 %
19.8
—
0
158
13.9
181
-3.2 %
15.9
44
-44.3 %
3.9
1
0.09
-1
-0.09
15
-74.6 %
1.3
2
0.2
13
-70.5 %
1.1
0.11
115
1 226
-6.6 %
100
960
78.3
266
12.7 %
21.7
—
0
166
13.5
187
2.7 %
15.3
79
46.3 %
6.4
—
0
1
0.08
59
15.7 %
4.8
15
1.2
44
12.8 %
3.6
0.38
115.1
1 312
—
100
1 076
82
236
—
18
—
0
161
12.3
182
—
13.9
54
—
4.1
—
0
—
0
51
—
3.9
12
0.9
39
—
3
0.34
115.1